The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Medical researchers helped tame a worldwide pandemic, but they may be powerless against the financial disease rapidly ...

Sellas Life Sciences Group, Inc.'s Phase 3 GPS trial sparks uncertainty; stock's a Hold. Interim results for GPS are promising but iffy. Click for more on SLS.

TriSalus Life Sciences expects 50% sales growth and EBITDA positivity in 2025. See why TLSI stock could benefit, with key ...

Mammals Were Adapting from Life in the Trees to Living on the Ground Before Dinosaur-Killing Asteroid Apr. 1, 2025 — More mammals were living on the ground several million years before the mass ...

The coverage for potential risks includes research and development to clinical trials, data management, and product ...

Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its ...

Cologuard is getting an upgrade after 10 years on the market, as Exact Sciences starts to roll out the new version of its ...

Even for an industry that depends on relentless innovation to thrive, life sciences have seen remarkable advancements in recent decades. From the Human Genome Project paving the way for precision ...

Excess weight in mid-life is a known risk factor for kidney ... published in the Proceedings of the National Academy of Sciences (PNAS).

2024 was pivotal for UK Life Sciences’ venture funding landscape. Softening macro and geopolitical conditions saw activity rebound, setting the stage for an upwards trajectory in 2025.

With unmatched durability, all-day battery life and revolutionary eye care display, the unbreakable AI smartphone sets itself ...